cell lines hepg 2 Search Results


95
CLS Cell Lines Service GmbH hepg2
Titration of AAV2/8 Luc in <t>HepG2</t> and Huh-7 liver cancer cells. Three multiplicities of infection (MOI) doses (10 4 , 10 5 , 10 6 —viral genomes) were tested in HepG2 ( upper panel) and in Huh-7 liver cancer cells ( lower panel) at three time points (24 h, 48 h, 72 h). Untransduced cells (CTL) were used as negative controls. Data are presented as mean ± SEM, n = 3.
Hepg2, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+hepg+2/pmc12984413-40-0-9?v=CLS+Cell+Lines+Service+GmbH
Average 95 stars, based on 1 article reviews
hepg2 - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier

95
Genecopoeia hepg2 cell line
Titration of AAV2/8 Luc in <t>HepG2</t> and Huh-7 liver cancer cells. Three multiplicities of infection (MOI) doses (10 4 , 10 5 , 10 6 —viral genomes) were tested in HepG2 ( upper panel) and in Huh-7 liver cancer cells ( lower panel) at three time points (24 h, 48 h, 72 h). Untransduced cells (CTL) were used as negative controls. Data are presented as mean ± SEM, n = 3.
Hepg2 Cell Line, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+hepg+2/pm36986177-66-6-26?v=Genecopoeia
Average 95 stars, based on 1 article reviews
hepg2 cell line - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier

91
Revvity hepg2 red fluc cell line
Titration of AAV2/8 Luc in <t>HepG2</t> and Huh-7 liver cancer cells. Three multiplicities of infection (MOI) doses (10 4 , 10 5 , 10 6 —viral genomes) were tested in HepG2 ( upper panel) and in Huh-7 liver cancer cells ( lower panel) at three time points (24 h, 48 h, 72 h). Untransduced cells (CTL) were used as negative controls. Data are presented as mean ± SEM, n = 3.
Hepg2 Red Fluc Cell Line, supplied by Revvity, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+hepg+2/pmc06802662-49-1-7?v=Revvity
Average 91 stars, based on 1 article reviews
hepg2 red fluc cell line - by Bioz Stars, 2026-07
91/100 stars
  Buy from Supplier

94
BPS Bioscience reporter hepg2 cell line
Titration of AAV2/8 Luc in <t>HepG2</t> and Huh-7 liver cancer cells. Three multiplicities of infection (MOI) doses (10 4 , 10 5 , 10 6 —viral genomes) were tested in HepG2 ( upper panel) and in Huh-7 liver cancer cells ( lower panel) at three time points (24 h, 48 h, 72 h). Untransduced cells (CTL) were used as negative controls. Data are presented as mean ± SEM, n = 3.
Reporter Hepg2 Cell Line, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+hepg+2/pm36009281-43-1-10?v=BPS+Bioscience
Average 94 stars, based on 1 article reviews
reporter hepg2 cell line - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

86
Korean Cell Line Bank caco 2 cell line
Titration of AAV2/8 Luc in <t>HepG2</t> and Huh-7 liver cancer cells. Three multiplicities of infection (MOI) doses (10 4 , 10 5 , 10 6 —viral genomes) were tested in HepG2 ( upper panel) and in Huh-7 liver cancer cells ( lower panel) at three time points (24 h, 48 h, 72 h). Untransduced cells (CTL) were used as negative controls. Data are presented as mean ± SEM, n = 3.
Caco 2 Cell Line, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+hepg+2/10__3390_slash_polysaccharides5030027-123-10-13?v=Korean+Cell+Line+Bank
Average 86 stars, based on 1 article reviews
caco 2 cell line - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

90
Broad Institute Inc ccle cancer cell line encyclopedia
Titration of AAV2/8 Luc in <t>HepG2</t> and Huh-7 liver cancer cells. Three multiplicities of infection (MOI) doses (10 4 , 10 5 , 10 6 —viral genomes) were tested in HepG2 ( upper panel) and in Huh-7 liver cancer cells ( lower panel) at three time points (24 h, 48 h, 72 h). Untransduced cells (CTL) were used as negative controls. Data are presented as mean ± SEM, n = 3.
Ccle Cancer Cell Line Encyclopedia, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+hepg+2/pmc08253281__CAS___112___2855___s001-14-17-1?v=Broad+Institute+Inc
Average 90 stars, based on 1 article reviews
ccle cancer cell line encyclopedia - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GenScript corporation human hepatoma hepg2 cell line
Titration of AAV2/8 Luc in <t>HepG2</t> and Huh-7 liver cancer cells. Three multiplicities of infection (MOI) doses (10 4 , 10 5 , 10 6 —viral genomes) were tested in HepG2 ( upper panel) and in Huh-7 liver cancer cells ( lower panel) at three time points (24 h, 48 h, 72 h). Untransduced cells (CTL) were used as negative controls. Data are presented as mean ± SEM, n = 3.
Human Hepatoma Hepg2 Cell Line, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+hepg+2/pm36828120-99-0-8?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
human hepatoma hepg2 cell line - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
iCell Gene Therapeutics human hsc line lx-2
Titration of AAV2/8 Luc in <t>HepG2</t> and Huh-7 liver cancer cells. Three multiplicities of infection (MOI) doses (10 4 , 10 5 , 10 6 —viral genomes) were tested in HepG2 ( upper panel) and in Huh-7 liver cancer cells ( lower panel) at three time points (24 h, 48 h, 72 h). Untransduced cells (CTL) were used as negative controls. Data are presented as mean ± SEM, n = 3.
Human Hsc Line Lx 2, supplied by iCell Gene Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+hepg+2/pm40550268-242-4-8?v=iCell+Gene+Therapeutics
Average 90 stars, based on 1 article reviews
human hsc line lx-2 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Hamamatsu hepg2.2.15 cell line
Titration of AAV2/8 Luc in <t>HepG2</t> and Huh-7 liver cancer cells. Three multiplicities of infection (MOI) doses (10 4 , 10 5 , 10 6 —viral genomes) were tested in HepG2 ( upper panel) and in Huh-7 liver cancer cells ( lower panel) at three time points (24 h, 48 h, 72 h). Untransduced cells (CTL) were used as negative controls. Data are presented as mean ± SEM, n = 3.
Hepg2.2.15 Cell Line, supplied by Hamamatsu, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+hepg+2/pm28745269-167-3-14?v=Hamamatsu
Average 90 stars, based on 1 article reviews
hepg2.2.15 cell line - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Choongwae Pharma Corporation hepg2.2.15 cell line
Titration of AAV2/8 Luc in <t>HepG2</t> and Huh-7 liver cancer cells. Three multiplicities of infection (MOI) doses (10 4 , 10 5 , 10 6 —viral genomes) were tested in HepG2 ( upper panel) and in Huh-7 liver cancer cells ( lower panel) at three time points (24 h, 48 h, 72 h). Untransduced cells (CTL) were used as negative controls. Data are presented as mean ± SEM, n = 3.
Hepg2.2.15 Cell Line, supplied by Choongwae Pharma Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+hepg+2/pm17015965-20-24-30?v=Choongwae+Pharma+Corporation
Average 90 stars, based on 1 article reviews
hepg2.2.15 cell line - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Biowhittaker Inc human hepatoma cell line hepg2
Titration of AAV2/8 Luc in <t>HepG2</t> and Huh-7 liver cancer cells. Three multiplicities of infection (MOI) doses (10 4 , 10 5 , 10 6 —viral genomes) were tested in HepG2 ( upper panel) and in Huh-7 liver cancer cells ( lower panel) at three time points (24 h, 48 h, 72 h). Untransduced cells (CTL) were used as negative controls. Data are presented as mean ± SEM, n = 3.
Human Hepatoma Cell Line Hepg2, supplied by Biowhittaker Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+hepg+2/10__1128_slash_mcb__22__11__3783___3793__2002-77-1-16?v=Biowhittaker+Inc
Average 90 stars, based on 1 article reviews
human hepatoma cell line hepg2 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Titration of AAV2/8 Luc in HepG2 and Huh-7 liver cancer cells. Three multiplicities of infection (MOI) doses (10 4 , 10 5 , 10 6 —viral genomes) were tested in HepG2 ( upper panel) and in Huh-7 liver cancer cells ( lower panel) at three time points (24 h, 48 h, 72 h). Untransduced cells (CTL) were used as negative controls. Data are presented as mean ± SEM, n = 3.

Journal: Cancers

Article Title: Transcriptional Control of Hepatocellular Carcinoma Cells Aggressiveness by AAV2/8-Mediated Delivery of Human Centenarian-Associated SIRT6 N308K/A313S

doi: 10.3390/cancers18050812

Figure Lengend Snippet: Titration of AAV2/8 Luc in HepG2 and Huh-7 liver cancer cells. Three multiplicities of infection (MOI) doses (10 4 , 10 5 , 10 6 —viral genomes) were tested in HepG2 ( upper panel) and in Huh-7 liver cancer cells ( lower panel) at three time points (24 h, 48 h, 72 h). Untransduced cells (CTL) were used as negative controls. Data are presented as mean ± SEM, n = 3.

Article Snippet: HepG2 and Huh-7 liver cancer cells were obtained from CLS-GmbH (Eppelheim, Germany) and were authenticated using STR profiling.

Techniques: Titration, Infection

mRNA expression of SIRT6 WT or SIRT6 Cent in HepG2 ( A ) and in Huh-7 ( B ) liver cancer cells. Cells were transduced with AAV2/8-Luc, AAV2/8-SIRT6-WT and AAV2/8-SIRT6-N308K/A313S for 48 h. mRNA levels of SIRT6 WT and SIRT6c were assessed by qPCR. Data are presented as mean ± SEM, n = 3. p < 0.001 (***) versus AAV2/8-Luc and AAV2/8-SIRT6-N308K/A313S-transduced cells.

Journal: Cancers

Article Title: Transcriptional Control of Hepatocellular Carcinoma Cells Aggressiveness by AAV2/8-Mediated Delivery of Human Centenarian-Associated SIRT6 N308K/A313S

doi: 10.3390/cancers18050812

Figure Lengend Snippet: mRNA expression of SIRT6 WT or SIRT6 Cent in HepG2 ( A ) and in Huh-7 ( B ) liver cancer cells. Cells were transduced with AAV2/8-Luc, AAV2/8-SIRT6-WT and AAV2/8-SIRT6-N308K/A313S for 48 h. mRNA levels of SIRT6 WT and SIRT6c were assessed by qPCR. Data are presented as mean ± SEM, n = 3. p < 0.001 (***) versus AAV2/8-Luc and AAV2/8-SIRT6-N308K/A313S-transduced cells.

Article Snippet: HepG2 and Huh-7 liver cancer cells were obtained from CLS-GmbH (Eppelheim, Germany) and were authenticated using STR profiling.

Techniques: Expressing, Transduction

MTT viability assays: MTT assay on HepG2 ( A ); and Huh-7 liver cancer cell line ( B ) transduced with AAV2/8-Luc, AAV2/8-SIRT6-WT and AAV2/8-SIRT6-N308K/A313S for up to five days (0 h, 24 h, 48 h, 72 h, 96 h, 120 h). Cell survivals were significantly lower in AAV2/8-SIRT6-WT and AAV2/8-SIRT6-N308K/A313S-transduced cells from AAV2-8-Luc at the indicated time points, with a p < 0.05 (*), p < 0.01 (**) or p < 0.001 (***). Data are presented as mean ± SEM, n = 3.

Journal: Cancers

Article Title: Transcriptional Control of Hepatocellular Carcinoma Cells Aggressiveness by AAV2/8-Mediated Delivery of Human Centenarian-Associated SIRT6 N308K/A313S

doi: 10.3390/cancers18050812

Figure Lengend Snippet: MTT viability assays: MTT assay on HepG2 ( A ); and Huh-7 liver cancer cell line ( B ) transduced with AAV2/8-Luc, AAV2/8-SIRT6-WT and AAV2/8-SIRT6-N308K/A313S for up to five days (0 h, 24 h, 48 h, 72 h, 96 h, 120 h). Cell survivals were significantly lower in AAV2/8-SIRT6-WT and AAV2/8-SIRT6-N308K/A313S-transduced cells from AAV2-8-Luc at the indicated time points, with a p < 0.05 (*), p < 0.01 (**) or p < 0.001 (***). Data are presented as mean ± SEM, n = 3.

Article Snippet: HepG2 and Huh-7 liver cancer cells were obtained from CLS-GmbH (Eppelheim, Germany) and were authenticated using STR profiling.

Techniques: MTT Assay, Transduction

Global transcriptomic profiling in hepatocellular carcinoma cells: two-dimensional principal component analysis (PCA) plots derived from variance-stabilized expression values (DESeq2) for HepG2 ( A ); and Huh7 ( B ) liver cancer cells. Each point represents an individual biological replicate, illustrating clear separation of samples according to experimental condition (Luc control, SIRT6-WT, and SIRT6-Cent), reflecting distinct overall gene-expression signatures.

Journal: Cancers

Article Title: Transcriptional Control of Hepatocellular Carcinoma Cells Aggressiveness by AAV2/8-Mediated Delivery of Human Centenarian-Associated SIRT6 N308K/A313S

doi: 10.3390/cancers18050812

Figure Lengend Snippet: Global transcriptomic profiling in hepatocellular carcinoma cells: two-dimensional principal component analysis (PCA) plots derived from variance-stabilized expression values (DESeq2) for HepG2 ( A ); and Huh7 ( B ) liver cancer cells. Each point represents an individual biological replicate, illustrating clear separation of samples according to experimental condition (Luc control, SIRT6-WT, and SIRT6-Cent), reflecting distinct overall gene-expression signatures.

Article Snippet: HepG2 and Huh-7 liver cancer cells were obtained from CLS-GmbH (Eppelheim, Germany) and were authenticated using STR profiling.

Techniques: Derivative Assay, Expressing, Control, Gene Expression

Differential expression and pathway analysis in HepG2 liver cancer cells: ( A ) volcano plots displaying differentially expressed genes across the three pairwise comparisons (SIRT6-WT vs. Luc, SIRT6-Cent vs. Luc, and SIRT6-Cent vs. SIRT6-WT). The horizontal axis shows log 2 fold-change, and the vertical axis indicates −log 10 (adjusted p -value). Upregulated genes are shown in blue, downregulated genes in red; and ( B ) reactome pathway enrichment results for the same comparisons. The bubble size corresponds to the number of differentially expressed genes contributing to each pathway, while color intensity reflects the degree of statistical enrichment.

Journal: Cancers

Article Title: Transcriptional Control of Hepatocellular Carcinoma Cells Aggressiveness by AAV2/8-Mediated Delivery of Human Centenarian-Associated SIRT6 N308K/A313S

doi: 10.3390/cancers18050812

Figure Lengend Snippet: Differential expression and pathway analysis in HepG2 liver cancer cells: ( A ) volcano plots displaying differentially expressed genes across the three pairwise comparisons (SIRT6-WT vs. Luc, SIRT6-Cent vs. Luc, and SIRT6-Cent vs. SIRT6-WT). The horizontal axis shows log 2 fold-change, and the vertical axis indicates −log 10 (adjusted p -value). Upregulated genes are shown in blue, downregulated genes in red; and ( B ) reactome pathway enrichment results for the same comparisons. The bubble size corresponds to the number of differentially expressed genes contributing to each pathway, while color intensity reflects the degree of statistical enrichment.

Article Snippet: HepG2 and Huh-7 liver cancer cells were obtained from CLS-GmbH (Eppelheim, Germany) and were authenticated using STR profiling.

Techniques: Quantitative Proteomics

Invasive capacity of HCC cells after SIRT6 overexpression: invasion through basement membrane-coated inserts was evaluated in HepG2 ( A ); and Huh7 ( B ) liver cancer cells 48 h after transduction with AAV2/8-Luc (control), AAV2/8-SIRT6-WT, or AAV2/8-SIRT6-N308K/A313S, followed by a 24 h migration period toward 10% FBS as chemoattractant. White bars: no chemoattractant (negative control); black bars: migration inducer provided with the kit (positive control). Both SIRT6-WT and the centenarian-associated SIRT6 variant dramatically reduced cell invasion compared with the Luc control. Data are presented as mean ± SEM, n = 3. Data are presented as mean ± SEM, n = 3. Statistical significance: * p < 0.05, ** p < 0.01, *** p < 0.001 versus AAV2/8-Luc; $$$ p < 0.001 versus AAV2/8-SIRT6-WT.

Journal: Cancers

Article Title: Transcriptional Control of Hepatocellular Carcinoma Cells Aggressiveness by AAV2/8-Mediated Delivery of Human Centenarian-Associated SIRT6 N308K/A313S

doi: 10.3390/cancers18050812

Figure Lengend Snippet: Invasive capacity of HCC cells after SIRT6 overexpression: invasion through basement membrane-coated inserts was evaluated in HepG2 ( A ); and Huh7 ( B ) liver cancer cells 48 h after transduction with AAV2/8-Luc (control), AAV2/8-SIRT6-WT, or AAV2/8-SIRT6-N308K/A313S, followed by a 24 h migration period toward 10% FBS as chemoattractant. White bars: no chemoattractant (negative control); black bars: migration inducer provided with the kit (positive control). Both SIRT6-WT and the centenarian-associated SIRT6 variant dramatically reduced cell invasion compared with the Luc control. Data are presented as mean ± SEM, n = 3. Data are presented as mean ± SEM, n = 3. Statistical significance: * p < 0.05, ** p < 0.01, *** p < 0.001 versus AAV2/8-Luc; $$$ p < 0.001 versus AAV2/8-SIRT6-WT.

Article Snippet: HepG2 and Huh-7 liver cancer cells were obtained from CLS-GmbH (Eppelheim, Germany) and were authenticated using STR profiling.

Techniques: Over Expression, Membrane, Transduction, Control, Migration, Negative Control, Positive Control, Variant Assay

Nanoindentation assays in: HepG2 ( A ); and Huh-7 liver cancer cell lines ( B ) transduced with AAV2/8-Luc, AAV2/8-SIRT6-WT and AAV2/8-SIRT6-N308K/A313S for two days prior to incubation in the Boyden chamber for a further 24 h; 10% FBS was used as chemoattractant. Cell stiffness (measured in Pascal, Pa) was significantly higher in AAV2/8- AAV2/8-SIRT6-N308K/A313S-transduced cells compared to AAV2/8-Luc and to AAV2/8-SIRT6-WT. p < 0.05 (*), p < 0.01 (**) versus AAV2/8-SIRT6-WT.

Journal: Cancers

Article Title: Transcriptional Control of Hepatocellular Carcinoma Cells Aggressiveness by AAV2/8-Mediated Delivery of Human Centenarian-Associated SIRT6 N308K/A313S

doi: 10.3390/cancers18050812

Figure Lengend Snippet: Nanoindentation assays in: HepG2 ( A ); and Huh-7 liver cancer cell lines ( B ) transduced with AAV2/8-Luc, AAV2/8-SIRT6-WT and AAV2/8-SIRT6-N308K/A313S for two days prior to incubation in the Boyden chamber for a further 24 h; 10% FBS was used as chemoattractant. Cell stiffness (measured in Pascal, Pa) was significantly higher in AAV2/8- AAV2/8-SIRT6-N308K/A313S-transduced cells compared to AAV2/8-Luc and to AAV2/8-SIRT6-WT. p < 0.05 (*), p < 0.01 (**) versus AAV2/8-SIRT6-WT.

Article Snippet: HepG2 and Huh-7 liver cancer cells were obtained from CLS-GmbH (Eppelheim, Germany) and were authenticated using STR profiling.

Techniques: Transduction, Incubation